Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation

Drug resistance is the major obstacle in successfully treating high-risk neuroblastoma. The aim of this study was to investigate the basis of etoposide-resistance in neuroblastoma. To this end, a MYCN-amplified neuroblastoma cell line (HTLA-230) was treated with increasing etoposide concentrations a...

Descripción completa

Detalles Bibliográficos
Autores principales: Marengo, Barbara, Monti, Paola, Miele, Mariangela, Menichini, Paola, Ottaggio, Laura, Foggetti, Giorgia, Pulliero, Alessandra, Izzotti, Alberto, Speciale, Andrea, Garbarino, Ombretta, Traverso, Nicola, Fronza, Gilberto, Domenicotti, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137223/
https://www.ncbi.nlm.nih.gov/pubmed/30213983
http://dx.doi.org/10.1038/s41598-018-32195-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137223/
https://www.ncbi.nlm.nih.gov/pubmed/30213983
http://dx.doi.org/10.1038/s41598-018-32195-7

Ejemplares similares